Effect of age on thymic development, T cell immunity, and helper T cell function

Author(s):  
S. S. Shen ◽  
J. S. Kim ◽  
M. E. Weksler
PLoS ONE ◽  
2017 ◽  
Vol 12 (1) ◽  
pp. e0170396 ◽  
Author(s):  
Victor H. Navas ◽  
Céline Cuche ◽  
Andres Alcover ◽  
Vincenzo Di Bartolo

2010 ◽  
Vol 54 (11) ◽  
pp. 691-701 ◽  
Author(s):  
Kentaro Aritomi ◽  
Taku Kuwabara ◽  
Yuriko Tanaka ◽  
Hideki Nakano ◽  
Takuwa Yasuda ◽  
...  

2011 ◽  
Vol 108 (22) ◽  
pp. 9220-9225 ◽  
Author(s):  
W. Niedbala ◽  
J. C. Alves-Filho ◽  
S. Y. Fukada ◽  
S. M. Vieira ◽  
A. Mitani ◽  
...  

2012 ◽  
Vol 145 (3) ◽  
pp. 230-240 ◽  
Author(s):  
Fengmin Shi ◽  
Xiaoqin Guo ◽  
Xingwei Jiang ◽  
Ping Zhou ◽  
Yan Xiao ◽  
...  

2010 ◽  
Vol 22 (4) ◽  
pp. 207-213 ◽  
Author(s):  
Christina Meyer ◽  
Xun Zeng ◽  
Yueh-hsiu Chien

2006 ◽  
Vol 15 (4) ◽  
pp. 255-263 ◽  
Author(s):  
Shiho Watanabe ◽  
Shuhei Ogawa ◽  
Yasushi Hara ◽  
Kazunari Tanabe ◽  
Hiroshi Toma ◽  
...  

2001 ◽  
Vol 193 (2) ◽  
pp. 233-238 ◽  
Author(s):  
Madhav V. Dhodapkar ◽  
Ralph M. Steinman ◽  
Joseph Krasovsky ◽  
Christian Munz ◽  
Nina Bhardwaj

Immunostimulatory properties of dendritic cells (DCs) are linked to their maturation state. Injection of mature DCs rapidly enhances antigen-specific CD4+ and CD8+ T cell immunity in humans. Here we describe the immune response to a single injection of immature DCs pulsed with influenza matrix peptide (MP) and keyhole limpet hemocyanin (KLH) in two healthy subjects. In contrast to prior findings using mature DCs, injection of immature DCs in both subjects led to the specific inhibition of MP-specific CD8+ T cell effector function in freshly isolated T cells and the appearance of MP-specific interleukin 10–producing cells. When pre- and postimmunization T cells were boosted in culture, there were greater numbers of MP-specific major histocompatibility complex tetramer-binding cells after immunization, but these had reduced interferon γ production and lacked killer activity. These data demonstrate the feasibility of antigen-specific inhibition of effector T cell function in vivo in humans and urge caution with the use of immature DCs when trying to enhance tumor or microbial immunity.


2021 ◽  
Author(s):  
Khalid W Kalim ◽  
Jun-Qi Yang ◽  
Mark Wunderlich ◽  
Vishnu Modur ◽  
Phuong Nguyen ◽  
...  

Regulatory T (Treg) cells play an important role in maintaining immune tolerance through inhibiting effector T cell function. In the tumor microenvironment, Treg cells are utilized by tumor cells to counteract effector T cell-mediated tumor killing. Targeting Treg cells may thus unleash the anti-tumor activity of effector T cells. While systemic depletion of Treg cells can cause excessive effector T cell responses and subsequent autoimmune diseases, controlled targeting of Treg cells may benefit cancer patients. Here we show that Treg cell-specific heterozygous deletion or pharmacological targeting of Cdc42 GTPase does not affect Treg cell numbers but induces Treg cell plasticity, leading to anti-tumor T cell immunity without detectable autoimmune reactions. Cdc42 targeting potentiates an immune checkpoint blocker anti-PD-1 antibody-mediated T cell response against mouse and human tumors. Mechanistically, Cdc42 targeting induces Treg cell plasticity and unleashes anti-tumor T cell immunity through carbonic anhydrase I-mediated pH changes. Thus, rational targeting of Cdc42 in Treg cells holds therapeutic promises in cancer immunotherapy.


2011 ◽  
Vol 31 (3) ◽  
pp. 296-301 ◽  
Author(s):  
Jun Shimizu ◽  
Hideshi Yoshikawa ◽  
Erika Takada ◽  
Chieko Hirotsu ◽  
Noboru Suzuki

Sign in / Sign up

Export Citation Format

Share Document